BioWorld MedTech

Dec. 29, 2014

U.S.-China talks focus on market access, intellectual property rights

A high-level trade meeting between the U.S. and China has placed the spotlight on increasing market access for medical devices while also putting a heavy emphasis on intellectual property rights issues. Read More

High hopes for the MDSAP certification pilot program

New initiatives in India proposed to strengthen medical device industry

Sink or swim, Google Glass will be a game changer for med-tech

AltheaDx files SEC papers for IPO up to $69 million

UMA sees measurable benefits from cloud-based UltiPro HCM software

Product Briefs

Keeping you up to date on recent developments in neurology

Today's news in brief

BioWorld

BioWorld briefs for Jan 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 16, 2026.

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Businesswoman pressing dollar sign on touchscreen

JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

BioWorld

It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...